[1]
A. Juda, K. Rojek, M. Kamińska, A. Strzoda, and A. Polak, “The use of the GLP-1 analog - dulaglutide in the treatment of morbid obesity - case report”, J Educ Health Sport, vol. 13, no. 1, pp. 146–152, Nov. 2022.